Zevra Therapeutics, Inc. has entered into a Merger Agreement with Acer Therapeutics Inc., where each share of Acer Common Stock will be converted into Zevra Common Stock and a Contingent Value Right; Zevra anticipates issuing 2,960,507 shares of Zevra Common Stock at the Effective Time.